AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 157 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $180,000 | +102.2% | 11,892 | +0.8% | 0.00% | +100.0% |
| Q2 2022 | $89,000 | -19.8% | 11,803 | -2.9% | 0.00% | 0.0% |
| Q1 2022 | $111,000 | +30.6% | 12,161 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $85,000 | -38.4% | 12,077 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $138,000 | -28.9% | 12,135 | +0.4% | 0.00% | -50.0% |
| Q2 2021 | $194,000 | -6.3% | 12,089 | +4.4% | 0.00% | 0.0% |
| Q1 2021 | $207,000 | +33.5% | 11,584 | +1.0% | 0.00% | +100.0% |
| Q4 2020 | $155,000 | +10.7% | 11,468 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $140,000 | +0.7% | 11,918 | +15.4% | 0.00% | -50.0% |
| Q1 2020 | $139,000 | – | 10,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |